Sports Medicine Protocol

PEMF for Achilles
Tendinopathy.

Up to 50% of runners experience Achilles symptoms — and the tendon absorbs loads up to 12× body weight per stride. Here is how PEMF supports soft-tissue repair as an adjunct to evidence-based eccentric loading.

← Back to Articles
Clinical foot and ankle examination for Achilles tendinopathy in a runner

Achilles tendinopathy is one of the most common overuse injuries in runners and endurance athletes — up to roughly 50% of runners experience Achilles symptoms at some point in their careers. The Achilles tendon is the strongest tendon in the body, yet it absorbs loads of up to 12× body weight with every running stride. When the cumulative load outpaces the tendon's capacity to repair, the result is pain, stiffness, and reduced performance.

PEMF (Pulsed Electromagnetic Field) therapy is a non-invasive treatment that supports soft-tissue repair processes alongside functional rehabilitation. It is painless, requires no medication, and can be delivered in a clinic setting without continuous supervision — making it an attractive adjunct in a sports medicine protocol.

The Headline Evidence

The strongest controlled evidence for PEMF in musculoskeletal pain comes from a 2025 prospective multi-center randomized controlled trial (PMC11914662) conducted across 5 orthopedic clinics with 91 patients:

  • 36% pain reduction in the PEMF group vs. 10% with standard care (p<0.0001)
  • 55% reduction in medication consumption

This RCT establishes a robust, clinically meaningful effect for PEMF on musculoskeletal pain. As we discuss below, this dataset is not Achilles-specific — but it forms the backbone of the evidence alongside well-characterized biological mechanisms.

How PEMF Works on the Tendon

PEMF acts on tendon tissue through several complementary mechanisms:

  • Improved blood flow and microcirculation — a vascular study (PubMed 32401418) documented increased local circulation, which is critical for a tendon that is naturally poorly vascularized.
  • Reduced inflammation — modulation of the local inflammatory response in soft tissue.
  • Cellular and ATP activity & collagen synthesis — supporting the fibroblast activity needed to rebuild tendon matrix.
  • Tissue repair support — the soft-tissue inflammation and repair effects of PEMF are reviewed by Strauch et al. (2009, PubMed 19371845).
  • Pain-signal modulation — reduction of nociceptive transmission, easing pain during the rehabilitation window.

An Honest Look at the Evidence

We believe in transparent communication with clinics and patients. Here is the honest framing: Achilles-specific RCT evidence for PEMF is limited. The case for PEMF in Achilles tendinopathy rests on (1) high-quality RCT data for joint and soft-tissue pain, and (2) general, well-established PEMF mechanisms of action on circulation, inflammation, and tissue repair.

For that reason, PEMF should be positioned as an adjunct to eccentric loading — the evidence-based foundation of Achilles rehabilitation — and not as a replacement for it. Eccentric loading remains the standard of care; PEMF supports the biological environment in which that loading does its work.

Mid-Portion vs. Insertional Achilles Tendinopathy

Not all Achilles tendinopathy is the same, and the distinction matters clinically:

  • Mid-portion tendinopathy affects the tendon body roughly 2–6 cm above the heel bone. It is the more common presentation and generally responds well to eccentric loading protocols.
  • Insertional tendinopathy occurs where the tendon attaches to the calcaneus (heel bone). It is more sensitive to compressive load, so loading must be modified (often avoiding deep dorsiflexion), and progress can be slower.

Correctly identifying which presentation you are treating shapes both the loading program and the PEMF coil placement.

The 3-Phase Clinical Protocol

PEMF integrates into a staged rehabilitation framework:

  1. Acute phase — calm pain and inflammation while reducing load relative to the athlete's normal training. PEMF supports pain-signal modulation and circulation during this settling period.
  2. Sub-acute phase — combine PEMF with graded eccentric loading. This is the core of the program: PEMF supports the tissue environment while progressive eccentric work rebuilds tendon capacity.
  3. Functional phase — a controlled return to running, calf strengthening, and biomechanics/gait work to address the factors that caused the overload in the first place.

Treatment frequency: 1–2 times per week, up to 3 times weekly in severe cases with a rest day between sessions. Some patients report improvement after only a few sessions, while full, measurable improvement typically develops over several weeks of consistent treatment combined with loading.

PEMF vs. Other Achilles Treatment Options

Parameter PEMF Shockwave (ESWT) Physiotherapy & Loading NSAIDs
Mechanism Improves microcirculation, reduces inflammation, supports collagen synthesis and tissue repair Acoustic energy stimulates a controlled micro-injury and remodeling response Mechanical eccentric load drives tendon adaptation and capacity Systemic anti-inflammatory and analgesic effect
Invasiveness Non-invasive Non-invasive (external applicator) Non-invasive Non-invasive (oral)
Patient experience during treatment Pleasant and painless May cause temporary local pain during the session Controlled effort and some discomfort during loading Painless to take (a pill)
Clinic supervision needed No continuous supervision required Requires a trained operator throughout Requires a therapist to coach and progress No clinic supervision; self-administered
Side effects / risk Very rare; excellent safety profile Temporary pain, redness, or bruising at the site Risk of flare-up if progressed too quickly GI, kidney, and cardiovascular risk with prolonged use
FDA status FDA cleared (510k) FDA cleared for certain indications Standard of care; not a device requiring clearance FDA approved (OTC and prescription)

Every technology has its place depending on the clinical situation. These options are not strictly either/or: in practice, combining shockwave + PEMF + physiotherapy and loading tends to give better results than any single modality alone.

Frequently Asked Questions

Is PEMF treatment painful?

No. PEMF is pleasant and painless — patients typically feel nothing or only a mild warmth. There are no needles and no medication, which makes it easy to combine with an active rehab program.

How long until I see improvement?

Some patients notice relief after just a few sessions. However, meaningful tendon repair takes time: full, measurable improvement usually develops over several weeks of consistent treatment combined with eccentric loading. Tendons remodel slowly by nature.

Can I keep training while undergoing treatment?

Often yes, but with modified load. In the acute phase, training volume should be reduced relative to your normal program. As you progress through the sub-acute and functional phases, controlled return to running is reintroduced. The goal is to keep you active without re-overloading the tendon.

Does PEMF replace eccentric loading exercises?

No — and this is important. Eccentric loading is the evidence-based foundation of Achilles rehabilitation. PEMF is an adjunct that supports the tissue environment; it is not a substitute for the loading program.

What is the operational benefit of PEMF for a clinic?

Unlike shockwave or hands-on physiotherapy, PEMF does not require continuous practitioner supervision during the session. A staff member can set up the patient and attend to other tasks, which improves clinic throughput and economics. Typical session pricing in the market is around ₱1,500–₱2,500 per session.

How should I combine PEMF with other treatments?

The strongest results come from combination, not isolation. A common approach pairs PEMF with shockwave and a structured physiotherapy and loading program — PEMF supporting circulation and repair, shockwave stimulating remodeling, and loading rebuilding tendon capacity.

Interested in adding PEMF to your clinic?

Request the full investment brief — machine specs, financials, and site selection for the Philippines market.

Request Investment Brief →

PainFree operates 70+ Israeli clinics serving a population of 9M — now expanding to the Philippines.